As a leader in this increasingly important field, our goal is to empower healthcare professionals in providing better and safer patient care using gas enabled solutions for patient treatment.
Our focus on pharmaceutical quality control in the complete chain of events for medical gases, from the production facility to the administration to the patient, increases the level of patient safety in hospitals and in homecare. In documenting the toxicological and clinical aspects of our medicinal gases, we have followed the guidelines for safety and efficacy documentation for “Well established products” set by the International Conference of Harmonisation (ICH). In the case of traditional medicinal gases such as oxygen and nitrous oxide, our documentation summarizes existing, public domain, scientific literature according to guidelines for so called "Well established products." With new gas enabled therapies, pre-clinical and clinical documentation follows the same development guidelines as for new pharmaceutical compounds.
By being independent of a specific provider for homecare equipment, Linde Gas Therapeutics can offer the latest equipment and set it up to the patient's individual needs. Our well-established infrastructure and experience in the Homecare business guarantee on-time delivery and patient education to maximize the outcome of treatment at home.